GlaxoSmithKline PLC
LSE:GSK
GlaxoSmithKline PLC
LSE:GSK
Price:
1 700.5 GBX
-0.26%
Updated:
May 2, 2024
GlaxoSmithKline PLC
Operating Income
|
GlaxoSmithKline PLC
Operating Income Peer Comparison
Comparables:
AZN
VRNA
INDV
HIK
DPH
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Operating Income
£8.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Operating Income
$8.9B
|
CAGR 3-Years
27%
|
CAGR 5-Years
30%
|
CAGR 10-Years
9%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Operating Income
-$67.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Operating Income
$270m
|
CAGR 3-Years
45%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Operating Income
$622m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Operating Income
£24.9m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
3%
|
See Also
What is GlaxoSmithKline PLC's Operating Income?
Operating Income
8.3B
GBP
8.3B
GBP
Based on the financial report for Dec 31, 2023, GlaxoSmithKline PLC's Operating Income amounts to 8.3B GBP.
What is GlaxoSmithKline PLC's Operating Income growth rate?
Operating Income CAGR 10Y
2%
2%
Over the last year, the Operating Income growth was -1%. The average annual Operating Income growth rates for GlaxoSmithKline PLC have been 11% over the past three years , and 2% over the past ten years .
You don't have any saved screeners yet
